Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2015

01-04-2015 | Epidemiology

Smoking and survival in female breast cancer patients

Authors: Alicia Padron-Monedero, Stacey L. Tannenbaum, Tulay Koru-Sengul, Feng Miao, Damien Hansra, David J. Lee, Margaret M. Byrne

Published in: Breast Cancer Research and Treatment | Issue 2/2015

Login to get access

Abstract

The purpose of this study was to determine if smoking affects survival in female breast cancer patients, both overall and stratified by race, ethnicity, and socioeconomic status. We linked data from the 1996–2007 Florida cancer data system, the Florida Agency for Health Care Administration, and the U.S. census. Inclusion criteria were females ≥18 years, diagnosed with breast cancer, and residing in Florida (n = 127,754). To analyze the association between smoking and survival, we performed sequential multivariate Cox proportional hazard regression models with progressive adjustment for main confounders. Compared to never smokers, worse survival was found in current (hazard ratio 1.33; 95 % CI 1.28–1.38) and former smokers (1.09; 1.06–1.13). Those who smoked <1, 1–2, and >2 packs/day had worse survival (HR 1.28; 1.20–1.36; HR 1.40; 1.33–1.47 and 1.70; 1.45–1.99, respectively) (p for linear trend <0.001), than never smokers. Among Whites, current and former smokers had worse survival (HR 1.38; 1.33–1.44 and HR 1.11; 1.07–1.15, respectively) than never smokers. Worse survival was also found for current and former smokers (HR 1.34; 1.29–1.40 and HR 1.10; 1.06–1.15, respectively) compared with never smokers among non-Hispanics; similarly, worse survival was found among current Hispanic smokers (HR 1.13; 1.01–1.26). The association was not significant for Blacks. Current smoking is associated with worse survival in White breast cancer patients and through all socioeconomic status categories and ethnicities compared to never smoking. Former smoking is associated with worse survival in White and non-Hispanic females. Blacks had similar survival regardless of smoking status. Nonetheless, all female breast cancer patients should be advised to quit smoking.
Literature
4.
go back to reference Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW (1994) Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol 139(10):1001–1007PubMed Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW (1994) Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol 139(10):1001–1007PubMed
5.
go back to reference Holmes MD, Murin S, Chen WY, Kroenke CH, Spiegelman D, Colditz GA (2007) Smoking and survival after breast cancer diagnosis. Int J Cancer 120(12):2672–2677CrossRefPubMed Holmes MD, Murin S, Chen WY, Kroenke CH, Spiegelman D, Colditz GA (2007) Smoking and survival after breast cancer diagnosis. Int J Cancer 120(12):2672–2677CrossRefPubMed
7.
go back to reference Manjer J, Andersson I, Berglund G, Bondesson L, Garne JP, Janzon L, Malina J, Matson S (2000) Survival of women with breast cancer in relation to smoking. Eur J Surg 166(11):852–858CrossRefPubMed Manjer J, Andersson I, Berglund G, Bondesson L, Garne JP, Janzon L, Malina J, Matson S (2000) Survival of women with breast cancer in relation to smoking. Eur J Surg 166(11):852–858CrossRefPubMed
8.
go back to reference Yu GP, Ostroff JS, Zhang ZF, Tang J, Schantz SP (1997) Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev 21(6):497–509PubMed Yu GP, Ostroff JS, Zhang ZF, Tang J, Schantz SP (1997) Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev 21(6):497–509PubMed
9.
go back to reference Wojcik BE, Spinks MK, Optenberg SA (1998) Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 82(7):1310–1318CrossRefPubMed Wojcik BE, Spinks MK, Optenberg SA (1998) Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 82(7):1310–1318CrossRefPubMed
12.
go back to reference Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6):439–448CrossRefPubMed Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6):439–448CrossRefPubMed
13.
go back to reference Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97(1):134–147CrossRefPubMed Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97(1):134–147CrossRefPubMed
15.
go back to reference Boscoe FP, Sherman C (2006) On socioeconomic Gradients in cancer registry data quality (letter). J Epidemiol Community Health 60:551PubMedCentralPubMed Boscoe FP, Sherman C (2006) On socioeconomic Gradients in cancer registry data quality (letter). J Epidemiol Community Health 60:551PubMedCentralPubMed
17.
go back to reference Satariano WA (1993) Aging, comorbidity, and breast cancer survival: an epidemiologic view. Adv Exp Med Biol 330:1–11CrossRefPubMed Satariano WA (1993) Aging, comorbidity, and breast cancer survival: an epidemiologic view. Adv Exp Med Biol 330:1–11CrossRefPubMed
18.
go back to reference Daniell HW (1988) Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer 62(2):429–435CrossRefPubMed Daniell HW (1988) Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer 62(2):429–435CrossRefPubMed
19.
go back to reference Woodward M, Tunstall-Pedoe H (1992) Biochemical evidence of persistent heavy smoking after a coronary diagnosis despite self-reported reduction: analysis from the Scottish Heart Health Study. Eur Heart J 13(2):160–165PubMed Woodward M, Tunstall-Pedoe H (1992) Biochemical evidence of persistent heavy smoking after a coronary diagnosis despite self-reported reduction: analysis from the Scottish Heart Health Study. Eur Heart J 13(2):160–165PubMed
Metadata
Title
Smoking and survival in female breast cancer patients
Authors
Alicia Padron-Monedero
Stacey L. Tannenbaum
Tulay Koru-Sengul
Feng Miao
Damien Hansra
David J. Lee
Margaret M. Byrne
Publication date
01-04-2015
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3317-3

Other articles of this Issue 2/2015

Breast Cancer Research and Treatment 2/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine